End-of-day quote
Taipei Exchange
06:00:00 2024-05-19 pm EDT
|
5-day change
|
1st Jan Change
|
32.6
TWD
|
+0.31%
|
|
+3.49%
|
-0.46%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
903.1
|
984
|
840.5
|
2,867
|
2,433
|
2,238
|
Enterprise Value (EV)
1 |
471.3
|
703.4
|
563.3
|
2,408
|
1,859
|
1,634
|
P/E ratio
|
7.63
x
|
-51.2
x
|
205
x
|
13.5
x
|
6.89
x
|
25.6
x
|
Yield
|
3.32%
|
-
|
0.98%
|
5.01%
|
9.83%
|
3.05%
|
Capitalization / Revenue
|
0.59
x
|
0.64
x
|
0.53
x
|
1.26
x
|
1.03
x
|
1.42
x
|
EV / Revenue
|
0.31
x
|
0.46
x
|
0.36
x
|
1.06
x
|
0.78
x
|
1.03
x
|
EV / EBITDA
|
10.6
x
|
12.1
x
|
6.04
x
|
6.24
x
|
3.71
x
|
10.7
x
|
EV / FCF
|
-3.32
x
|
287
x
|
-892
x
|
24.7
x
|
11.6
x
|
6.42
x
|
FCF Yield
|
-30.2%
|
0.35%
|
-0.11%
|
4.04%
|
8.63%
|
15.6%
|
Price to Book
|
0.64
x
|
0.77
x
|
0.65
x
|
1.89
x
|
1.4
x
|
1.42
x
|
Nbr of stocks (in thousands)
|
67,452
|
68,334
|
68,334
|
68,334
|
68,334
|
68,334
|
Reference price
2 |
13.39
|
14.40
|
12.30
|
41.95
|
35.60
|
32.75
|
Announcement Date
|
4/1/19
|
3/31/20
|
3/29/21
|
3/25/22
|
3/29/23
|
3/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,524
|
1,533
|
1,585
|
2,269
|
2,369
|
1,580
|
EBITDA
1 |
44.48
|
57.92
|
93.24
|
385.9
|
501.6
|
152.3
|
EBIT
1 |
-44.39
|
-28.35
|
6.683
|
302.7
|
422.6
|
81.31
|
Operating Margin
|
-2.91%
|
-1.85%
|
0.42%
|
13.34%
|
17.83%
|
5.15%
|
Earnings before Tax (EBT)
1 |
149.6
|
-13.26
|
10.54
|
302.4
|
490
|
121.6
|
Net income
1 |
120.2
|
-20.51
|
4.412
|
213.2
|
358.9
|
88.18
|
Net margin
|
7.89%
|
-1.34%
|
0.28%
|
9.4%
|
15.15%
|
5.58%
|
EPS
2 |
1.756
|
-0.2811
|
0.0600
|
3.100
|
5.170
|
1.280
|
Free Cash Flow
1 |
-142.1
|
2.454
|
-0.6311
|
97.39
|
160.5
|
254.8
|
FCF margin
|
-9.33%
|
0.16%
|
-0.04%
|
4.29%
|
6.77%
|
16.12%
|
FCF Conversion (EBITDA)
|
-
|
4.24%
|
-
|
25.24%
|
31.99%
|
167.25%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
45.68%
|
44.72%
|
288.92%
|
Dividend per Share
2 |
0.4444
|
-
|
0.1200
|
2.100
|
3.500
|
1.000
|
Announcement Date
|
4/1/19
|
3/31/20
|
3/29/21
|
3/25/22
|
3/29/23
|
3/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
432
|
281
|
277
|
458
|
574
|
604
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-142
|
2.45
|
-0.63
|
97.4
|
160
|
255
|
ROE (net income / shareholders' equity)
|
8.72%
|
-1.52%
|
0.34%
|
15.2%
|
22%
|
5.31%
|
ROA (Net income/ Total Assets)
|
-1.4%
|
-0.87%
|
0.21%
|
8.65%
|
10.6%
|
2.16%
|
Assets
1 |
-8,597
|
2,346
|
2,084
|
2,466
|
3,380
|
4,085
|
Book Value Per Share
2 |
21.00
|
18.70
|
18.80
|
22.20
|
25.50
|
23.10
|
Cash Flow per Share
2 |
7.370
|
6.150
|
7.480
|
9.450
|
9.250
|
9.110
|
Capex
1 |
153
|
83.2
|
44.2
|
63
|
145
|
59.8
|
Capex / Sales
|
10.07%
|
5.43%
|
2.79%
|
2.78%
|
6.1%
|
3.78%
|
Announcement Date
|
4/1/19
|
3/31/20
|
3/29/21
|
3/25/22
|
3/29/23
|
3/25/24
|
|
1st Jan change
|
Capi.
|
---|
| -0.46% | 68.97M | | +10.67% | 33.8B | | +28.91% | 8.62B | | +16.22% | 8.22B | | +27.39% | 5.8B | | -5.07% | 4.04B | | +17.08% | 3.8B | | +14.17% | 3.71B | | +23.12% | 3.69B | | -5.70% | 2.81B |
Testing & Measuring Equipment
|